Published in Vaccine Weekly, October 1st, 2003
"Tumor-induced immunosuppression is one of the crucial mechanisms of tumor evasion of immune surveillance. It contributes greatly to the failure of cancer vaccines. Immature myeloid cells (ImCs) play an important role in tumor-induced immunosuppression," scientists in the United States report.
"These cells accumulate in large numbers in tumor-bearing hosts and directly inhibit T-cell functions via various mechanisms," stated Sergei Kusmartsev and colleagues at the University of South Florida. "In this study, we tried to eliminate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.